Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model.

Ahmed, Yossra; Ali, Zeinab Y; Mohamed, Mona A; Rashed, Laila A; Mohamed, Ehsan K

Ahmed, Yossra; Ali, Zeinab Y; Mohamed, Mona A; Rashed, Laila A; Mohamed, Ehsan K.

Afiliação

Ahmed Y; King Saud University, Riyadh, Saudi Arabia.
Ali ZY; Faculty of Science, Al-Azhar University (Girls Branch), Cairo, Egypt.
Mohamed MA; National Organization of Drug Control and Research, Cairo, Egypt.
Rashed LA; Biochemistry Unit, Chemistry Department, Faculty of Science, Al-Azhar University (Girls Branch), Cairo, Egypt.
Mohamed EK; Biochemistry Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

J Diabetes Metab Disord ; 20(1): 551-560, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34222076

Palavras-chave

C/EBP homologous protein (CHOP); Insulin sensitivity; Mesenchymal stem cells; Metabolic syndrome; Sitagliptin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article